Feed Preview

CfDNA Sequencing

CfDNA Sequencing diagram by Rashedul Islam Rony, Wikimedia
Rashedul Islam Rony, Wikimedia

Circulating free DNA (cfDNA) are degraded DNA fragments released to the blood plasma. cfDNA has been shown to be a useful biomarker for a multitude of ailments other than cancer and fetal medicine. Here is the latest research on Circulating free DNA (cfDNA) sequencing.

Top 20 most recent papers

Longitudinal whole-exome sequencing of cell-free DNA unravels the metastatic evolutionary dynamics of BRCA2 mutated breast cancer

bioRxivJanuary 10, 2020
Robert K HastingsJacqueline A Shaw
PloS One

Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability

PloS OneJanuary 14, 2020
Paula E NorthAoy Tomita-Mitchell
BioMed Research International

Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019

BioMed Research InternationalJanuary 14, 2020
Niki ChristouMuriel Mathonnet

Estimating the rate of cell type degeneration from epigenetic sequencing of cell-free DNA

bioRxivJanuary 16, 2020
Christa CaggianoNoah Zaitlen
Genetics in Medicine : Official Journal of the American College of Medical Genetics

Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises

Genetics in Medicine : Official Journal of the American College of Medical GeneticsJanuary 14, 2020
Glenn E PalomakiJohn A Thorson

ABEMUS: platform specific and data informed detection of somatic SNVs in cfDNA

BioinformaticsJanuary 11, 2020
Nicola CasiraghiAlessandro Romanel
The Breast : Official Journal of the European Society of Mastology

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

The Breast : Official Journal of the European Society of MastologyJanuary 14, 2020
Xiuwen GuanFei Ma
Genome Medicine

Molecular profiling for precision cancer therapies

Genome MedicineJanuary 16, 2020
Eoghan R MaloneLillian L Siu
ACS Applied Materials & Interfaces

Dynamically Monitoring the Clonal Evolution of Lung Cancer Based on the Molecular Characterization of Circulating Tumor Cells using Aptamer Cocktail-Modified Nanosubstrates

ACS Applied Materials & InterfacesJanuary 16, 2020
Ying ZhuZunfu Ke
Molecular Diagnosis & Therapy

Liquid Biopsy Applications in the Clinic

Molecular Diagnosis & TherapyJanuary 11, 2020
Dake ChenJian Chen
Clinica Chimica Acta; International Journal of Clinical Chemistry

Emerging biomarkers in Multiple Myeloma: A Review

Clinica Chimica Acta; International Journal of Clinical ChemistryJanuary 7, 2020
Nidhi GuptaAlpana Sharma
Frontiers in Physiology

Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives

Frontiers in PhysiologyJanuary 11, 2020
Marta CristaldiVera Panzarella
Clinical and Translational Medicine

Detection of bladder cancer using urinary cell-free DNA and cellular DNA

Clinical and Translational MedicineJanuary 16, 2020
Zhenyu OuZhuo Song

Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?

CancersJanuary 17, 2020
Nicoletta CoccaroFrancesco Albano
Cancer Investigation

Evaluation of a liquid biopsy protocol using ultra-deep massive parallel sequencing for detecting and quantifying circulation tumor DNA in colorectal cancer patients

Cancer InvestigationJanuary 16, 2020
Huu Thinh NguyenHoai-Nghia Nguyen
Nano Convergence

Direct electrophoretic microRNA preparation from clinical samples using nanofilter membrane

Nano ConvergenceJanuary 14, 2020
Kidan LeeKi-Bum Kim
Gynecologic Oncology

Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China

Gynecologic OncologyJanuary 16, 2020
Shang-Ying HuFang-Hui Zhao
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology

Cell-free mitochondrial DNA increases in maternal circulation during healthy pregnancy: a prospective, longitudinal study

American Journal of Physiology. Regulatory, Integrative and Comparative PhysiologyJanuary 9, 2020
Spencer C CushenStyliani Goulopoulou
OncoTargets and Therapy

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer

OncoTargets and TherapyJanuary 11, 2020
Qian ChenJing-He Lang
American Journal of Translational Research

Principles of digital PCR and its applications in current obstetrical and gynecological diseases

American Journal of Translational ResearchJanuary 15, 2020
Xiaodong MaoKangsheng Liu

See more papers from this feed

Related Feeds

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.


Chromatin Immunoprecipitation followed by sequencing (ChIP-seq) is a genome-wide technique used to map histone marks and protein binding (ie transcription factors) on chromatin. This can reveal insight into the regulation and dynamics of gene expression. Discover the latest research on ChIP-seq here.

Circulating Tumor DNA

Cancer cells produce circulating tumor DNA (ctDNA) which can be found in the blood stream using novel high-throughput sequencing technologies. Here is the latest research on ctDNA.

Comparative Sequencing

Inter/Intra-Species: Comparative Sequencing describes the sequencing techniques that compare between and within species genomes. Discover the latest research on comparative sequencing of inter/intra-species here.

DNA Repair & Genome Editing

Development of gene editing techniques, including CRISPR and TALENs, has relied on mechanisms that underlie DNA repair and genome stability pathways. This feed focuses on the role of DNA repair mechanisms in gene editing and genetic engineering.

© 2020 Meta ULC. All rights reserved